Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 49 (2015): Issue 1 (March 2015)
Open Access
A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer
Dirk Rades
Dirk Rades
,
Stefan Huttenlocher
Stefan Huttenlocher
,
Amira Bajrovic
Amira Bajrovic
,
Johann H. Karstens
Johann H. Karstens
and
Tobias Bartscht
Tobias Bartscht
| Mar 03, 2015
Radiology and Oncology
Volume 49 (2015): Issue 1 (March 2015)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Mar 03, 2015
Page range:
86 - 90
Received:
Jun 29, 2014
Accepted:
Sep 29, 2014
DOI:
https://doi.org/10.2478/raon-2014-0043
Keywords
esophageal cancer
,
spinal cord compression
,
metastatic
,
epidural
,
irradiation
,
survival
,
predictive instrument
© by Dirk Rades
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Dirk Rades
Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
Stefan Huttenlocher
Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
Amira Bajrovic
Department of Radiation Oncology, University Medical Center Eppendorf, Hamburg, Germany
Johann H. Karstens
Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
Tobias Bartscht
Department of Hematology and Medical Oncology, University of Lubeck, Lubeck, Germany